Our Professional Conclusion on Injection Sites So, where does our team land in this debate
We did not receive any public comments on our proposal to continue to remove claim lines reported with modifier PN from the ratesetting process and are finalizing as proposed
But these claims by thought leaders are despite the fact that BPC-157 has very little safety data and no rigorous human clinical trials an aberration of sorts for something commonly injected into the body by its users
Studies have included patients ranging from young adults to those over 75 years, with no clinically relevant age-related differences in pharmacokinetics
L-Valine, L-Glutamine, L-Glycine, L-Proline, L-Lysine, L-Alanine, L-Arginine, L-Histidine, L-Leucine, L-Tyrosine, L-Serine, L-Threonine, L-Isoleucine, L-Tryptophan, L-Methionine